Scroll to top
Tag: cost-effectiveness

Does AI Have the Emotional Intelligence to Supplement Mental Healthcare?

Article Excerpt: Mental healthcare is on the verge of a significant transformation with algorithms emerging as potential allies in the treatment process. However, the inherent bias in generative AI poses a critical question: what are the implications for patient outcomes?

Full Article:

Article Source: Omnia Health


Telehealth Proves Successful for Opioid Use Disorder Treatment

Article Excerpt: Virtual care provider Ophelia found 56% of its OUD patients remained in treatment for six months and 48% stayed for one year, with retention rates significantly higher than traditional in-person care…”These study findings help take another step forward in proving what we already know: telehealth-based medication-assisted treatment for opioid use disorder is highly effective in reducing overdoses and preventing relapse,” (Chief medical officer at Ophelia) said.

Full Article:

Article Source: Healthcare IT News


Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials

Rohrbach P, Dingemans A, Evers C, Van Furth E, Spinhoven P, Aardoom J, Lähde I, Clemens F, Van den Akker-Van Marle M. Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Med Internet Res 2023;25:e38204. DOI: 10.2196/38204

A systematic review and meta-analysis were conducted to investigate the cost-effectiveness of internet interventions for mental disorders compared to usual care. Eligibility criteria for included studies were randomized controlled trials with participants who reported any mental health disorder or symptoms, an intervention that was phone- or internet-based, reported outcomes on both quality of life and costs, and published in English. Researchers extracted data to report risk of bias, quality of the economic evaluation, quality-adjusted life years, and costs. The incremental net monetary benefit was calculated and pooled. Thirty-seven studies met eligibility criteria. Overall, the quality of economic evaluations was rated as moderate and the risk of bias as high. Internet interventions were slightly more effective in improving quality of life than usual care (Hedges g=0.052, p=.02) but with similar cost (Hedges g=0.002, p=.96). The pooled incremental net benefit was $255 (95% CI $91 to $419), favoring internet interventions over usual care. This review is a starting point for researchers to further understand the cost-effectiveness of internet interventions for mental disorders. Future work could investigate studies with more homogenous interventions or designs. Additionally, studies from non-Western cultures or low-income countries were not included in this review. To conclude, the cost-effectiveness of internet interventions compared with usual care is likely but not guaranteed.


The Future of Remote Medicine: The AMA Presents a Framework for Measuring Telehealth Quality

Article Excerpt: Under the simultaneous pressures of a pandemic-driven explosion in the use of telehealth, a growing emphasis on value-based care, and the current state of medical technology, the healthcare industry is undergoing what appear to be fundamental changes as a consequence of the high and irreversible growth of telehealth… In December 2022, the American Medical Association (AMA), in partnership with Manatt Health, released the “Return on Health” report that develops a framework to more precisely and holistically measure the value of telehealth through detailed case studies. This initiative also focuses on the challenges and opportunities for virtual care.(1) The adoption of the latest technology is essential to the expansion of telehealth beyond routine patient care.

Full Article:

Article Source: Imaging Technology News


Systematic review of economic evaluations for internet- and mobile-based interventions for mental health problems

Kählke F, Buntrock C, Smit F, Ebert DD. Systematic review of economic evaluations for internet- and mobile-based interventions for mental health problems. npj Digit. Med. 5, 175 (2022).

A systematic review was conducted to summarize the cost-effectiveness of internet and mobile-based interventions (IMIs) for mental health disorders and symptoms. This review also assessed methodological quality of included studies. The literature search identified studies of psychological interventions provided in an online setting to treat mental health disorders or any type of psychological symptoms regardless of participant age. Studies had to be randomized controlled trials that included a full economic evaluation. A total of 4,044 articles were identified, of which 36 articles met eligibility criteria. Sixty-five economic evaluations were conducted. The most commonly targeted mental health problem was major depressive disorder or depressive symptoms, followed by anxiety. Cost-effectiveness was determined using the threshold of at or below £30,000 per quality-adjusted life year (QALY) gained. Overall, the majority of economic evaluations of IMIs (n=56) presented evidence of cost-effectiveness. Guided IMIs (i.e., interventions that include support by a provider via email, chat, or automated feedback delivery) were likely to be cost-effective in depression and anxiety studies. Methodological quality of the cost-effectiveness analyses was mostly evaluated as good, however a few studies showed high risk of bias. Researchers found high heterogeneity across studies due to factors such as costing methods, design, comparators, and outcomes used. Overall, these findings suggest the cost-effectiveness of IMIs and include new evidence in under-researched disorders such as obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), stress, and sleep. Future research is needed to continue to target underrepresented disorders (e.g., panic disorder and specific phobias), as well as research in low- and middle-income countries.


Weill Cornell Medicine Awarded NIH Grant to Address Opioid Health Crisis

Article Excerpt: Weill Cornell Medicine has been awarded a five-year, $8.1 million grant from the National Institutes of Health (NIH) to support economic analysis, simulation modeling and other research approaches to help stem the national opioid epidemic. “We’ve continued to witness the very disturbing increase in opioid overdoses over the last seven years, fueled by more fentanyl in the drug supply,” said principal investigator Dr. Bruce Schackman, the Saul P. Steinberg Distinguished Professor of Population Health Sciences and director of the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCB, and HIV (CHERISH) at Weill Cornell Medicine. “Opioid overdoses are now the highest they’ve ever been. That’s been a big driver of a greater national focus on treatment and interventions to reduce overdoses.”

Full Article:

Article Source: Weill Cornell Medicine News


Willingness to pay for a telemedicine delivered healthy lifestyle programme

Rauch VK, Roderka M, Weintraub AB, Curtis K, Kotz DF, Rothstein RI, Batsis JA. Willingness to pay for a telemedicine-delivered healthy lifestyle programme. Journal of Telemedicine and Telecare. 2022;28(7):517-523. doi:10.1177/1357633X20943337

This study explored how willing rural adults were to pay for a remote weight-management program. Researchers conducted a single arm pilot study with 27 adult patients recruited from a medical weight and wellness center. Participants received a 16-week intervention focused on healthy behavior changes, including mindfulness, movement, problem-solving, and nutrition. In the program, a health coach, registered dietician, and nurse exercise specialist delivered weekly 30-minute one-on-one telehealth visits with participants. Researchers collected willingness-to-pay in a two-item survey at baseline and week 16 that asked: 1) at what point they would trade in person visits for telehealth based on commute time to reach the medical center, and 2) whether they would be willing to engage in a telehealth visit with an upfront cost for services. Participants who commute 30-45 minutes reported the highest willingness to trade in-person visits with telemedicine out of all groups. There was a significant increase in participants who would be willing to pay $30 or less for telemedicine from baseline (58%) to 16-week follow-up (69%). There was no significant difference over time in participants’ willingness to pay for telemedicine based on commute times. In qualitative interviews with participants, a majority found the program helpful. Participants also reported the intervention helped reduce travel time and expenses and increased flexibility for families and work. Results demonstrated that in rural areas, a digital weight management program could be acceptable and cost-effective. Research with a larger sample size and longer duration is needed to more accurately gauge patients’ willingness-to-pay for remote program delivery.


Digital Therapeutic for Substance Use Disorder Drives Down Care Utilization, Cost

Article Excerpt: Digital therapeutics firm Pear Therapeutics has released new data showing its prescription substance use disorder (SUD) therapy reduces hospitalizations and lowers healthcare costs for patients. The data will be published in the journal Advances in Therapy, but the findings are currently available online as a pre-print. The treatment is called reSET. The app is built around cognitive behavioral therapy (CBT) utilizing the community reinforcement approach (CRA), the company said. It includes a 12-week course of therapy, in which patients are incentivized for completing lessons and abstaining from drug use. The app also includes fluency training designed to reinforce the lesson content. Previous studies have shown the therapy can be effective at improving rates of abstinence and treatment retention when coupled with usual treatments. In the new report, investigators wanted to know how such improvements might translate into changes in healthcare resource utilization and costs.

Full Article:

Article Source: Managed Healthcare Executive


Clinical effectiveness and cost-effectiveness of videoconference-based integrated cognitive behavioral therapy for chronic pain: Randomized controlled trial

Taguchi K, Numata N, Takanashi R, Takemura R, Yoshida T, Kutsuzawa K, Yoshimura K, Nozaki-Taguchi N, Ohtori S, Shimizu E. (2021). Clinical effectiveness and cost-effectiveness of videoconference-based integrated cognitive behavioral therapy for chronic pain: Randomized controlled trial. J Med Internet Res 2021;23(11):e30690. DOI: 10.2196/30690

Researchers conducted a study to test the effectiveness and cost-effectiveness of a 16-session cognitive behavioral therapy (CBT) program delivered through video calls for the management of chronic pain. 30 participants with chronic pain were randomly assigned to the CBT program or treatment as usual (continued outpatient consultations). The CBT program included 16 weekly videoconference sessions with a therapist and covered sessions on psychoeducation on pain, relaxation exercises, cognitive reconstruction, tactile attention-shift training, memory work, behavioral image training, and video feedback. Participants completed assessments at baseline, mid-intervention, and post-intervention to measure change in pain intensity, pain severity, pain interference, mental health, quality of life and cost utility. There was no significant difference in changes in pain intensity between the two groups. However, the treatment group reported significant improvement in pain interference and quality of life. Additionally, it was found that the incremental cost-effectiveness ratio for a year was estimated at 2.9 million yen (or 25,000 USD) per quality-adjusted life year gained. Findings indicate that a video-conference CBT treatment protocol can be a beneficial supplement to medical treatment for chronic pain. There was some support for the cost-efficiency of this telehealth intervention, but this result needs to be verified with a larger sample.